Body mass index and the risk of incident noncommunicable diseases after starting antiretroviral therapy. | Vanderbilt Center for Clinical Cardiovascular Outcomes Research and Trials Evaluation

Koethe JR, Jenkins CA, Turner M, Bebawy S, Shepherd BE, Wester CW, Sterling TR. Body mass index and the risk of incident noncommunicable diseases after starting antiretroviral therapy. HIV medicine. 2015 Jan;16(16). 67-72. PMID: 25230709 [PubMed] PMCID: PMC4268383 NIHMSID: NIHMS602350.

Abstract

Obesity and HIV infection are associated with an increased incidence of noninfectious comorbid medical conditions, but the relationship between body mass index (BMI) and the development of noncommunicable diseases (NCDs) among individuals on antiretroviral therapy (ART) has not been well characterized.